TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes of oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of immune tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in global health status/quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gynecological cancer awareness scale change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual Attitudes and Beliefs Scale Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentages of fetal cells in immune cell subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: abdominal muscle thickening fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EELZ (end-expiration lung impedance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Virologically confirmed symptomatic COVID-19 cases
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of adverse events of special interests (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Segmental Resection Conversion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants with Post Operative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Obstetric Quality of Recovery-10 (ObsQoR-10) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: WOMAC Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: McGill Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Generalized Anxiety Disorder scale 7 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative nausea and vomiting evaluation
Endpoint domain: Adverse events/effects
Primary endpoint: Carriage of N.meningitidis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Muscular moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Identification of a causal genetic variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO ordinal Covid-19 scale up to day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual mechanisms of intermediate distance space perception (distance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual mechanisms of intermediate distance space perception (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Functional Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of iodine in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of serum albumin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement rate of ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total intravenous (IV) morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Graft height in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft width in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical Symptoms Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS Global Health Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Radial height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sarmiento radiological score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dose limited tolerance (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Extended lipid panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Factor IX level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Thromboelastography (TEG) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Overall Response Rate (ORR) After Neoadjuvant treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fetal Haemoglobin (HbF) Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in frequency of blood transfusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of adjudicated Vaso-occlusive crisis (VOC) events with a medical contact
Endpoint domain: Adverse events/effects
Primary endpoint: Time to onset of first adjudicated Vaso-occlusive crisis (VOC)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in standardised T-score on the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue 7a Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cognitive level measured by MMSE scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Provisional prosthesis fit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician interaction time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Wound morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neonatal bone mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Target vein occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from Baseline in HAMD-17
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of CKD among pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinician Administered PTSD Scale-5 Revised (CAPS-5 R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Liebowitz Social Anxiety Scale (LSAS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neutrophil Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Basement Membrane Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squamous Metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymphocytic Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: prevention of preterm preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Pattern of ILD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Social and emotional well-being status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adherence to Medication Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rational Drug Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in monthly menstrual frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Neuroinflammation Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood creatine kinase variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of cramps in CKD III-V patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of gas/solid microemboli detected by TCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Scale of Morningness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Death due to cardiovascular causes or thromboembolic events
Endpoint domain: Mortality/survival
Primary endpoint: Surface muscle temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma Inorganic Pyrophosphate (PPi) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 12-Month Positive Aortic Remodeling Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activities-Specific Balance Confidence Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in augmentation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Patient's satisfaction with breasts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Scores 1 or 2 on the WHO Ordinal Scale at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of positive cerebral spinal fluid ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: External and Internal Shame Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Belongingness Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: VMO muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean difference in Chalder Fatigue Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in ctDNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the algorithm at detecting infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: R-value measured with tubomanometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning curves of time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of HIV care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participant enrollment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant adherence to the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cortical mean transit time (mTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female sexual satisfaction and functionality scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Retained in Care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Number of Participants with Viral Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine calcium-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of LFR260 on Visual Acuity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of LFR260 in Repeated Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean arterial pressure outside limits of cerebral autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Estimated Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new Myocardial Infarction after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of new Stroke after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who experience a Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of adverse events and treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: The 6-month PFS proportion by RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Peak oxygen consumption (V02P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of preoperative speech rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Intravitreal Injection Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of pain in the eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn's body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the algorithm to distinguish between living twin and demised twin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Covid-19 symptoms management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral load assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objective circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bioimpedance spectroscopy measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response rate based on the modified Mayo score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration of the drug (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative duration of deviations in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change from baseline in contractile muscle volume (CMV) of quadriceps femoris muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of vasopressor support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opiate consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SLICC/ACR damage index (SDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed Serum Concentration (Ctrough) of Amivantamab at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed Serum Concentration (Ctrough) of Amivantamab at Pre-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve (AUC[Day 1-15]) of Amivantamab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest Plasma Concentration (Ctrough)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC0-6weeks)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of H.pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean scores of KIDSCREEN-27
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative norepinephrine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Best Recorded Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Injection Interval at 12 Months of Brolucizumab Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of eyes with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Perineal wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Intracardiac Geometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device technical success and procedural safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant reintervention
Endpoint domain: Adverse events/effects
Primary endpoint: Urine Culture Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leukocytes Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Nitrites Presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine pH Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cortisol from baseline to first follow-up assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in cortisol from baseline to second follow-up assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Risk factors of thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freedom from clinically-driven target lesion revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of Serious Adverse Device Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Back and Leg Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Participant Self-rated satisfaction with various aspects of their home and neighborhood
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Self-efficacy in ability to continue essential life activities
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Diagnostic accuracy of 0.55T MRI in detecting prostate suspicious lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intracranial objective response rate (iORR)
Endpoint domain: Mortality/survival
Primary endpoint: Overall recruitment feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall intervention feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity: Linkage manager adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recovery community center attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of recovery support services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of major stroke
Endpoint domain: Mortality/survival
Primary endpoint: Headache intensity measured by Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in chronic insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incidence rate of new or worsening heart failure due to systolic dysfunction
Endpoint domain: Mortality/survival
Primary endpoint: Change in resting left ventricular outflow tract (LVOT) gradient from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six Minutes Walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of medication directions and triaging of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to prescribed medication dosing and schedule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver attendance with youth at 1 or more treatment appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Amplitude of the Late Positive Potential (LPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-dimensional spatio-temporal blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plaque progression (stenosis degree)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Fruit+Vegetable Intake as Measured by Skin Carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Fruit+Vegetable Intake as Measured by Self-Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Balance index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk muscles endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline postpartum depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline postpartum anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline parental stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative incidence of graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes